Refractory epilepsyepilepsyA. muciniphilaWMTwashed microbiota transplantation
…Background Refractory epilepsy remains a global clinical challenge. This first-in-humans cohor…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 117 of 2459metoclopramideondansetronCisplatincisplatin-based
… symptom control and lower therapy inadequacy risks compared to metoclopramide.Conclusions Ondansetron is superior to metoclopramide for preve…
gastric cancerMITSUK BiobankUKBGCUGCEDUpper Gastrointestinal Cancer Early Detection ProgramSITgastric lesion
…40% of the global population and is the primary risk factor for gastric cancer (GC). However, genome-wide evidence on host genetic susceptibil…
experimental colitisIBDchronic colitisT cell transfer colitisacute dextran sodium sulfate colitisGPR15L
…static phenotype. Rectal supplementation of GPR15L counteracted experimental colitis. In patients with IBD, GPR15L expression was decreased in activ…
Non-small cell lung cancerChemoradiotherapyNSCLC[18F] FDGAmerican College of Radiology Imaging Network[18F]Fluorodeoxyglucose[18F]FDG[18F] fluorodeoxyglucoseCancer Imaging Archive
…aortic blood poolAbstract 35 Figure 1Graphical abstract. NSCLC: Non-small cell lung cancer, PET: Positron Emission Tomography, CT: Computed Tomography, [1…
interstitial lung diseaseCOPDchronic obstructive pulmonary diseaseO 2ILDAmerican Thoracic Society
…ong-term supplemental oxygen therapy (O 2) for individuals with interstitial lung disease who experience hypoxaemia due to its potential to improve sympt…
Central India Eye and Medical StudyBeijing Eye StudyUral Eye and Medical StudyUral Children Eye StudyUral Very Old StudyGLONNGONnon-glaucomatous optic neuropathy
…e: 85+ years), Ural Children Eye Study (n=4328; age: 6+ years), Central India Eye and Medical Study (n=4374; age: 30+ years) underwent medical and ophthalmological…
Alexandria Main University HospitalHCCcirrhosishepatocellular carcinoma
…ients in Egypt.Methods This case-control study was conducted at Alexandria Main University Hospital. Data collection took place between February and December 2025 …
ketamineketamine-inducedKetamine-associateddecompensated liver diseasecholangiopathyUropathy
…ported cases, yet the consequences can be similarly severe.With ketamine use rising across Europe over the past decade, we have observed…
Robarts Histopathology IndexGUSGuselkumabCDCrohn’s disease
…ic response and histo-endoscopic remission were evaluated using Robarts Histopathology Index (RHI), Global Histologic Activity Score (GHAS), and Geboes scor…
vedolizumabVedolizumab64ustekinumabulcerative colitisCrohn’s diseaseAzathioprineInflammatory Bowel DiseaseP19 inhibitorsIBDP19 inhibitors51+3 more
… restricted with only 50.7% of services reporting access.In CD, vedolizumab was accessible in 64/71 services (90.1%), including 31 (43.7%) …